- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ovarian Neoplasm
Total 107107 results
-
Leiden University Medical CenterUniversity Medical Center GroningenCompletedRecurrent Ovarian CancerNetherlands
-
Wuhan UniversityUnknown
-
Northwestern UniversityNational Cancer Institute (NCI)TerminatedOvarian CancerUnited States
-
GERCOR - Multidisciplinary Oncology Cooperative...Unknown
-
Nuvectis Pharma, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingOvarian Cancer | Ovarian Endometrioid Adenocarcinoma | Advanced Solid Tumor | Ovarian Clear Cell Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Clear Cell Tumor | Ovarian Endometrioid Tumor | ARID1A Gene MutationUnited States, United Kingdom
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedMalignant Ovarian Epithelial Tumor | Ovarian Gynandroblastoma | Ovarian Sertoli-Leydig Cell Tumor | Ovarian Sex Cord Tumor With Annular Tubules | Ovarian Steroid Cell Tumor | Ovarian Granulosa Cell Tumor | Ovarian Sex Cord-Stromal Tumor | Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell...United States
-
Fudan UniversityNot yet recruitingRecurrent Ovarian CancerChina
-
Women's Hospital School Of Medicine Zhejiang UniversityRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRecurrent Platinum-resistant Ovarian CancerChina
-
West China Second University HospitalRecruitingNeoadjuvant Chemotherapy | Epithelial Carcinoma, OvarianChina
-
Cukurova UniversityRecruitingEpithelial Ovarian Cancer | Rectosigmoid Cancer MetastaticTurkey
-
Haukeland University HospitalHelse Stavanger HF; Sorlandet Hospital HFRecruiting
-
Marker Therapeutics, Inc.TerminatedOvarian Cancer | Platinum Sensitive Ovarian CancerUnited States
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
Jonsson Comprehensive Cancer CenterCompleted
-
National Cancer Center, KoreaAjou UniversityCompletedEpithelial Ovarian CancerKorea, Republic of
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Ovarian CancerChina
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
PEDRO VILLAREJO CAMPOSUniversity of Castilla-La Mancha; Hospital General de Ciudad RealUnknownEpithelial Ovarian CancerSpain
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Mateon TherapeuticsTerminatedPlatinum Resistant Ovarian CancerUnited States, Belgium, Germany
-
Charite University, Berlin, GermanyWithdrawnRight Ventricular Function and Venous ReturnGermany
-
Dr. Reddy's Laboratories LimitedCompletedOvarian Epithelial Cancer RecurrentIndia
-
Esperance Pharmaceuticals IncCompletedOvarian Cancer RecurrentUnited States
-
University of GlasgowCompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
University of ChicagoNational Cancer Institute (NCI)WithdrawnOvarian CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)Terminated
-
Astellas Pharma IncOSI PharmaceuticalsCompletedOvarian NeoplasmsUnited Kingdom, United States
-
University of AarhusAarhus University Hospital; Danish Cancer Society; University of Southern DenmarkCompletedHealth and Coping Undergoing Ovarian Cancer Surgery. | Cancer RehabilitationDenmark
-
Grupo Español de Investigación en Cáncer de OvarioPharmaMarCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian CancerUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer
-
Bital Savir-BaruchBlue Earth DiagnosticsUnknownCervical Cancer | Ovarian Epithelial Cancer | Endometrial CancerUnited States
-
New Mexico Cancer Care AllianceAlliance Healthcare FoundationCompletedPain | Breast Cancer | Ovarian NeoplasmUnited States
-
TetraLogic PharmaceuticalsCompletedRelapsed Epithelial Ovarian Cancer | Relapsed Primary Peritoneal Cancer | Relapsed Fallopian Tube CancerUnited States
-
Centre Francois BaclesseGroupement Interrégional de Recherche Clinique et d'InnovationCompletedOvarian Cancer With Peritoneal CarcinosisFrance
-
University Hospital, ToursUnknown
-
Biocity Biopharmaceutics Co., Ltd.Not yet recruitingAdvanced Ovarian Cancer | Serous Ovarian Cancer
-
Radboud University Medical CenterRecruitingEpithelial Ovarian Cancer | Ovarian CarcinomaNetherlands
-
Steinar AamdalTerminatedRecurrent Epithelial Ovarian CancerNorway
-
Hoffmann-La RocheCompletedOvarian Cancer, Peritoneal NeoplasmsAustria
-
Peking University Third HospitalCompletedPCOS (Polycystic Ovary Syndrome) of Bilateral OvariesChina
-
Washington University School of MedicineCompletedOvarian Cancer | Cancer of the Ovary | Ovary Cancer | Neoplasms, Ovarian | Ovary Neoplasms | Cancer of OvaryUnited States
-
GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, OvarianUnited States, Australia, Singapore
-
Genelux CorporationGOG FoundationRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Platinum-refractory Ovarian Cancer | Primary Peritoneal Cancer | High-grade Serous Ovarian Cancer | Endometrioid Ovarian Cancer | Ovarian Clear Cell CarcinomaUnited States
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States